CNS Pharmaceuticals, Inc.
CNSP
$5.78
-$0.16-2.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.99M | 2.95M | 7.20M | 9.86M | 12.13M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.87M | 1.10M | 856.30K | 1.48M | 1.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 73.00K | 27.20K | 45.50K | 43.70K | 14.20K |
| Total Current Assets | 21.92M | 4.08M | 8.10M | 11.39M | 14.14M |
|
|
|||||
| Total Current Assets | 21.92M | 4.08M | 8.10M | 11.39M | 14.14M |
| Net Property, Plant & Equipment | 15.00K | 22.00K | 17.70K | 3.10K | 3.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 552.80K | 503.00K | 474.40K | 366.30K |
| Total Assets | 21.94M | 4.65M | 8.62M | 11.87M | 14.51M |
|
|
|||||
| Total Accounts Payable | 3.74M | 4.35M | 3.77M | 1.93M | 1.26M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 232.40K | 328.60K | 30.80K | 121.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.74M | 4.58M | 4.10M | 1.96M | 1.38M |
|
|
|||||
| Total Current Liabilities | 3.74M | 4.58M | 4.10M | 1.96M | 1.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 232.40K | 328.60K | 30.80K | 121.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.74M | 4.58M | 4.10M | 1.96M | 1.38M |
|
|
|||||
| Common Stock & APIC | 126.00M | 105.28M | 104.80M | 104.23M | 104.23M |
| Retained Earnings | -107.80M | -105.21M | -100.28M | -94.32M | -91.10M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 18.20M | 70.70K | 4.52M | 9.91M | 13.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.20M | 70.70K | 4.52M | 9.91M | 13.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.20M | 70.70K | 4.52M | 9.91M | 13.13M |
|
|
|||||